DIA
Drug Information Association Logo
« Back to Listing

Drug Development and the Virtual Company

Track:
Project/Portfolio Management and Strategic Planning

Day & Time:
June 17, 8:00AM - 9:30AM (Pacific Standard Time)

Session Number:
204

Room Number:
5A

Level:
Advanced

Type:
Forum

Title:
Drug Development and the Virtual Company

Chair(s):
Carrie Nodgaard Helland, MBA, PMP
Vice President, Project Management and Manufacturing
CytRx Corporation, United States

Description:
This forum will explore drug development at the virtual biotechnology company through cash planning, management, and control for development programs; the role of the project manager; and partnering and outsourcing.

Learning Objective(s):
Demonstrate techniques for managing global drug development at a small, virtual company in the areas of cash management, project management and outsourcing; Discuss techniques to budget and forecast with limited cash flow, for virtual team management; Describe strategies for structuring outsourcing contracts in order to minimize risk to capital.

Presentation(s) & Speaker(s):
Drug Development and the Virtual Company: Project Management
Haley Laken, PhD
Director
Tesaro, United States

Drug Development and the Virtual Company: Outsourcing
Anca Maria Copaescu, MBA, MSc
Senior Director, Clinical Outsourcing and Analytics
BioMarin Pharmaceutical Inc., United States

Drug Development and the Virtual Company: Cash Management
Carrie Nodgaard Helland, MBA, PMP
Vice President, Project Management and Manufacturing
CytRx Corporation, United States